Showing results (271-280 of 310) with videos related to
Sort By:
Pageof 31
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2020
Stimulator of interferon genes (STING) is an essential proviral host factor for human rhinovirus species A and CKevin L McKnight, Karen V Swanson, Kathryn Austgen, et al.The Journal of Antimicrobial Chemotherapy|November 1, 2016
Clofazimine has delayed antimicrobial activity against Mycobacterium tuberculosis both in vitro and in vivoNicole C Ammerman, Rosemary V Swanson, Asa Tapley, et al.Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|December 8, 2023
US air pollution is associated with increased incidence of non-syndromic cleft lip/palateKelsi N Krakauer, Priscila C Cevallos, Uche O Amakiri, et al.Gene|October 23, 1997
Identification and transcriptional analysis of a Treponema pallidum operon encoding a putative ABC transport system, an iron-activated repressor protein homolog, and a glycolytic pathway enzyme homologJ M Hardham, L V Stamm, S F Porcella, et al.Issues in Mental Health Nursing|August 6, 2013
Prevention of postpartum traumatic stress in mothers with preterm infants: manual development and evaluationRichard J Shaw, Carrie J Sweester, Nicholas St John, et al.Neurobiology of Disease|September 28, 2025
A meta-analysis of genetic variant pathogenicity and sex differences in UBQLN2-linked amyotrophic lateral sclerosis and frontotemporal dementiaKyrah M Thumbadoo, Laura R Nementzik, Molly E V Swanson, et al.Journal of Medicinal Chemistry|September 11, 2024
Discovery of TYRA-300: First Oral Selective FGFR3 Inhibitor for the Treatment of Urothelial Cancers and AchondroplasiaRobert L Hudkins, Eric Allen, Alexandra Balcer, et al.Medical and Pediatric Oncology|January 1, 1979
Childhood leukemia and lymphoma: correlation of clinical features with immunological and morphological studiesJ J Quinn, C R Taylor, V Swanson, et al.Journal of Medicinal Chemistry|March 31, 2026
Structure-Based Design of a Novel Covalent 4-(1-Methylindol-3-yl)pyrimidin-2-amine Series Targeting FGFR2 Resistance MutationsRobert L Hudkins, Eric Allen, Samhita Iyer, et al.Molecular Cancer Therapeutics|October 14, 2025
Dabogratinib (TYRA-300), an FGFR3 isoform-selective inhibitor: preclinical and initial clinical evidence of anti-tumor activityJacqueline H Starrett, Eric L Allen, Melissa Neal, et al.Pageof 31